Mohan Beltangady

4.9k total citations · 1 hit paper
40 papers, 3.0k citations indexed

About

Mohan Beltangady is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Infectious Diseases. According to data from OpenAlex, Mohan Beltangady has authored 40 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 17 papers in Pathology and Forensic Medicine and 9 papers in Infectious Diseases. Recurrent topics in Mohan Beltangady's work include Sarcoma Diagnosis and Treatment (23 papers), Tumors and Oncological Cases (14 papers) and HIV/AIDS drug development and treatment (7 papers). Mohan Beltangady is often cited by papers focused on Sarcoma Diagnosis and Treatment (23 papers), Tumors and Oncological Cases (14 papers) and HIV/AIDS drug development and treatment (7 papers). Mohan Beltangady collaborates with scholars based in United States, Canada and Switzerland. Mohan Beltangady's co-authors include Harold M. Maurer, William A. Newton, Walter Lawrence, Moody D. Wharam, Melvin Tefft, Daniel M. Hays, Ruth Heyn, Bruce L. Webber, Edward H. Soule and Edmund A. Gehan and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Mohan Beltangady

40 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The intergroup rhabdomyosarcoma study-I.A final report

1988 690 citations Harold M. Maurer, William M. Crist et al. Cancer profile →

Peers

Mohan Beltangady

PRM

PFM

ONCOL

RHEUM

SURGE

Tom Powles United Kingdom

Milton H. Donaldson United States

H Brincker Denmark

Ariela Noy United States

Silvia Montoto United Kingdom

Vijay P. Khatri United States

Jean Gabarre France

Johannes Blom Sweden

C Charnsangavej United States

Jeffrey Clarke United States

Tom Powles United Kingdom

Mohan Beltangady

659 ×0.3

PRM

709 ×0.7

PFM

1.5k ×1.6

ONCOL

218 ×0.2

RHEUM

1.1k ×1.6

SURGE

Citations per year, relative to Mohan Beltangady Mohan Beltangady (= 1×) peers Tom Powles

Countries citing papers authored by Mohan Beltangady

Since Specialization

Citations

This map shows the geographic impact of Mohan Beltangady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohan Beltangady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohan Beltangady more than expected).

Fields of papers citing papers by Mohan Beltangady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohan Beltangady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohan Beltangady. The network helps show where Mohan Beltangady may publish in the future.

Co-authorship network of co-authors of Mohan Beltangady

This figure shows the co-authorship network connecting the top 25 collaborators of Mohan Beltangady. A scholar is included among the top collaborators of Mohan Beltangady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohan Beltangady. Mohan Beltangady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barter, Philip J., Kerry‐Anne Rye, Mohan Beltangady, et al.. (2012). Relationship between atorvastatin dose and the harm caused by torcetrapib. Journal of Lipid Research. 53(11). 2436–2442. 7 indexed citations

Chuang‐Stein, Christy & Mohan Beltangady. (2010). Reporting cumulative proportion of subjects with an adverse event based on data from multiple studies. Pharmaceutical Statistics. 10(1). 3–7. 29 indexed citations

Shear, Charles L., Mohan Beltangady, William C. Ports, William Duggan, & Philip J. Barter. (2008). Abstract 1694: Torcetrapib: Predictors of Increased Clinical Risk in the Illuminate Study. Circulation. 118(3). e2667–e2667. 1 indexed citations

Seidman, Andrew D., Russell K. Portenoy, T. J. Yao, et al.. (1995). Quality of Life in Phase II Trials: a Study of Methodology and Predictive Value in Patients With Advanced Breast Cancer Treated With Paclitaxel Plus Granulocyte Colony-Stimulating Factor. JNCI Journal of the National Cancer Institute. 87(17). 1316–1322. 85 indexed citations

Grasela, Thaddeus H., Mohan Beltangady, C A Knupp, et al.. (1994). Analysis of Potential Risk Factors Associated with the Development of Pancreatitis in Phase I Patients with AIDS or AIDS-Related Complex Receiving Didanosine. The Journal of Infectious Diseases. 169(6). 1250–1255. 21 indexed citations

Beltangady, Mohan, Catherine A. Knupp, Nancy Gustafson, et al.. (1993). Relation Between Plasma Concentrations of Didanosine and Markers of Antiviral Efficacy in Adults with AIDS or AIDS-Related Complex. Clinical Infectious Diseases. 16(Supplement_1). S26–S31. 11 indexed citations

McLaren, C., Marcel Rozencweig, Mohan Beltangady, et al.. (1993). Longitudinal Analysis of Responses to Oral Didanosine Therapy Following Zidovudine Therapy in Advanced Infection with Human Immunodeficiency Virus. Clinical Infectious Diseases. 16(Supplement_1). S32–S39. 3 indexed citations

Kahn, James O., Stephen W. Lagakos, Douglas D. Richman, et al.. (1992). A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection. New England Journal of Medicine. 327(9). 581–587. 257 indexed citations

Crist, W M, Lisa Garnsey, Mohan Beltangady, et al.. (1990). Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee.. Journal of Clinical Oncology. 8(3). 443–452. 211 indexed citations

10.

Heyn, R, Mohan Beltangady, Walter Lawrence, et al.. (1989). Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study.. Journal of Clinical Oncology. 7(2). 200–207. 32 indexed citations

11.

Beltangady, Mohan & Ralph F. Frankowski. (1989). Effect of unequal censoring on the size and power of the logrank and Wilcoxon types of tests for survival data. Statistics in Medicine. 8(8). 937–945. 15 indexed citations

12.

Hays, Daniel M., Walter Lawrence, Moody D. Wharam, et al.. (1989). Primary reexcision for patients with ‘microscopic residual’ tumor following initial excision of sarcomas of trunk and extremity sites. Journal of Pediatric Surgery. 24(1). 5–10. 69 indexed citations

13.

Maurer, Harold M., William M. Crist, Walter Lawrence, et al.. (1988). The intergroup rhabdomyosarcoma study-I.A final report. Cancer. 61(2). 209–220. 690 indexed citations breakdown →

14.

Lawrence, Walter, Daniel M. Hays, Ruth Heyn, Mohan Beltangady, & Harold M. Maurer. (1988). Surgical lessons from the Intergroup Rhabdomyosarcoma Study (IRS) pertaining to extremity tumors. World Journal of Surgery. 12(5). 676–684. 25 indexed citations

15.

Newton, William A., E H Soule, Ala B. Hamoudi, et al.. (1988). Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation.. Journal of Clinical Oncology. 6(1). 67–75. 189 indexed citations

16.

Hays, Daniel M., Hiroyuki Shimada, R. Beverly Raney, et al.. (1988). Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents. Cancer. 61(9). 1893–1903. 45 indexed citations

17.

Shimada, Hiroyuki, William A. Newton, Edward H. Soule, Mohan Beltangady, & Harold M. Maurer. (1987). Pathology of fatal rhabdomyosarcoma. Report from intergroup rhabdomyosarcoma study (IRS-I and IRS-II). Cancer. 59(3). 459–465. 51 indexed citations

18.

Lawrence, Walter, Daniel M. Hays, Ruth Heyn, et al.. (1987). Lymphatic metastases with childhood rhabdomyosarcoma. A report from the intergroup rhabdomyosarcoma study. Cancer. 60(4). 910–915. 94 indexed citations

19.

Wharam, Moody D., Mohan Beltangady, R Heyn, et al.. (1987). Pediatric Orofacial and Laryngopharyngeal Rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study Report. Archives of Otolaryngology - Head and Neck Surgery. 113(11). 1225–1227. 29 indexed citations

20.

Ragab, Abdelsalam H., et al.. (1986). Infants younger than 1 year of age with rhabdomyosarcoma. Cancer. 58(12). 2606–2610. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact